TYLOSIN 10 DIN 00713481
Health Canada record
| Active ingredient(s) | TYLOSIN (TYLOSIN PHOSPHATE) 22 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1989 |
| Current status date | 07-Jun-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bio Agri Mix LP — licence 100068, currently licensed, last inspection rating C (2024-04-02).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TYLOSIN (TYLOSIN PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02397846 | PHARMASIN 100 | HUVEPHARMA EOOD | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 220 G | Marketed |
| 02515385 | PHARMASIN 40 | HUVEPHARMA EOOD | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 88 G | Marketed |
| 02242023 | TYLAN 100 | ELANCO CANADA LIMITED | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 220 G | Marketed |
| 00474444 | TYLAN 40 | ELANCO CANADA LIMITED | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 88 G | Marketed |
| 02472058 | TYLOSIN 100 | BIO AGRI MIX LP | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 220 G | Marketed |
| 00800422 | TYLOSIN 40 | BIO AGRI MIX LP | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 88 G | Marketed |
| 00103624 | TYLAN 10 | ELANCO CANADA LIMITED | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 22 G | Dormant |
| 00637645 | TYLAN 50/SULFA G PREMIX | ELANCO DIVISION ELI LILLY CANADA INC | Drug Premix | TYLOSIN (TYLOSIN PHOSPHATE) 110 G; SULFAMETHAZINE 110 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20253 | 2018-01-08 | Supplement to an Abbreviated New Drug Submission (SANDS) | CHANGE TO PRESCRIPTION STATUS. LABELLING UPDATES |
| 6083 | 2002-06-25 | Supplement to a New Drug Submission (SNDS) | NEW ZERO-DAY WITHDRAWAL TIME WHEN FED TO SWINE AT 110 MG TYLOSIN PER KG OF COMPLETE FEED (IN THE ABSENCE OF CONCURRENT TYLOSIN USE IN DRINKING WATER) |
| 6602 | 1999-06-07 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR AN ADDITIONAL CLAIM AS AN AID IN THE PREVENTION OF PORCINE PROLIFERATIVE ENTEROPATHY |